ADI
70
-6
URI
42
-26
F
56
-6
ROK
42
-20
FOXA
63
4
GE
68
-2
KEY
74
2
A
40
-3
L
69
4
MLM
61
-5
ICE
62
2
ALLE
46
5
WY
54
-11
TMO
56
-11
KMX
40
-7
SO
48
-29
ESS
47
8
USB
64
-12
CRM
52
2
TRV
49
-16
ADI
70
-6
URI
42
-26
F
56
-6
ROK
42
-20
FOXA
63
4
GE
68
-2
KEY
74
2
A
40
-3
L
69
4
MLM
61
-5
ICE
62
2
ALLE
46
5
WY
54
-11
TMO
56
-11
KMX
40
-7
SO
48
-29
ESS
47
8
USB
64
-12
CRM
52
2
TRV
49
-16
Financhill
Back

Columbia Research Enhanced Emerging Economies ETF Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison

Sell
44

ECON
Columbia Research Enhanced Emerging Economies ETF

Last Price:
$26.87
Seasonality Move:
0.33%
Buy
57

DRUG
Bright Minds Biosciences, Inc.

Last Price:
$88.46
Seasonality Move:
-32.16%
Sell
44
Columbia Research Enhanced Emerging Economies ETF (ECON) is a Sell

Is Columbia Research Enhanced Emerging Economies ETF a Buy, Sell or Hold?

  • The current Columbia Research Enhanced Emerging Economies ETF [ECON] share price is $26.79. The Score for ECON is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • ECON is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Bright Minds Biosciences, Inc. (DRUG) is a Buy

Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?

  • The current Bright Minds Biosciences, Inc. [DRUG] share price is $88.08. The Score for DRUG is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • DRUG is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ECON Stock Price Chart

What is Columbia Research Enhanced Emerging Economies ETF's stock price today?

  • The Columbia Research Enhanced Emerging Economies ETF share price today is $26.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ECON is experiencing selling pressure, which indicates risk of future bearish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences, Inc.'s stock price today?

  • The Bright Minds Biosciences, Inc. share price today is $88.08
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight selling pressure.

ECON Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 41.19 Sell
Chaikin Money Flow: -5098 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.83 - 27.47) Sell
Bollinger Bands (100): (25.22 - 27.56) Buy

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.77 Buy
Relative Strength Index (14 RSI): 66.44 Buy
Chaikin Money Flow: -23974 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (59.51 - 82.89) Buy
Bollinger Bands (100): (41.26 - 68.88) Buy

ECON Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.19 Sell
20-day SMA: 27.08 Sell
50-day SMA: 27.32 Sell
200-day SMA: 24.51 Buy
8-day EMA: 27.1 Sell
20-day EMA: 27.18 Sell
50-day EMA: 27.04 Sell
200-day EMA: 25.06 Buy

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 85.48 Buy
20-day SMA: 74.4 Buy
50-day SMA: 65.57 Buy
200-day SMA: 42.82 Buy
8-day EMA: 85.2 Buy
20-day EMA: 77.09 Buy
50-day EMA: 66.93 Buy
200-day EMA: 47.3 Buy

Columbia Research Enhanced Emerging Economies ETF Earnings Growth & ECON Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $3.34 per share.

Columbia Research Enhanced Emerging Economies ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):